Association Between Body Mass Index and Survival Outcomes In Patients Treated With Immune Checkpoint Inhibitors: Meta-analyses of Individual Patient Data-Reference-Cited by-同舟云学术

Association Between Body Mass Index and Survival Outcomes In Patients Treated With Immune Checkpoint Inhibitors: Meta-analyses of Individual Patient Data

Published:2021-08-30 Issue:9 Volume:44 Page:371-375
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Nie Run-Cong,Chen Guo-Ming,Wang Yun,Yuan Shu-Qiang,Zhou Jie,Duan Jin-Ling,Liu Wen-Wu,Chen Shi,Cai Mu-Yan,Li Yuan-Fang

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference29 articles.

1. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat Rev Cancer,2012

2. Cancer immunotherapy using checkpoint blockade;Ribas;Science,2018

3. Comprehensive analysis of the clinical immuno-oncology landscape;Tang;Ann Oncol,2018

4. A paradigm shift in cancer immunotherapy: from enhancement to normalization;Sanmamed;Cell,2018

5. The efficacy and safety of PD-1/PD-L1 inhibitors in combination with conventional therapies for advanced solid tumors: a meta-analysis;Nie;Biomed Res Int,2020

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Body Mass Index on Melanoma Biology, Immunotherapy Efficacy, and Clinical Outcomes: A Narrative Review;International Journal of Molecular Sciences;2024-06-11

2. Body mass index as a possible predictor of the development of endocrine immune-mediated adverse events during immune checkpoint inhibitors therapy;Obesity and metabolism;2024-03-06

3. Body composition and checkpoint inhibitor treatment outcomes in advanced melanoma: a multicenter cohort study;2024-03-02

4. Predictive Factors in Metastatic Melanoma Treated with Immune Checkpoint Inhibitors: From Clinical Practice to Future Perspective;Cancers;2023-12-24

5. Prognostic value of obesity in patients with cancer treated with immune checkpoint inhibitors: An updated meta‑analysis and systematic review;Molecular and Clinical Oncology;2023-11-21